CNS Cancer

13 registered clinical trials studyying CNS Cancer — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent NCT06322342	Reveal Pharmaceuticals Inc.	Phase 2
Recruiting	Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors NCT05313191	The New York Proton Center	N/A
Recruiting	Avera Cancer Sequencing and Analytics Protocol (ASAP) NCT05142033	Avera McKennan Hospital & University Health Center	—
Completed	The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479	Taproot Health	—
Completed	Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescen NCT04023669	St. Jude Children's Research Hospital	Phase 1
Completed	Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma NCT00589784	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	Language Function in Patients With Brain Tumors NCT00599703	Memorial Sloan Kettering Cancer Center	—
Completed	Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors NCT00594633	Memorial Sloan Kettering Cancer Center	Phase 1
Completed	Study of D-Methadone in Patients With Chronic Pain NCT00588640	Memorial Sloan Kettering Cancer Center	Phase 1 / Phase 2
Completed	Imaging Brain Tumors With FACBC and Methionine NCT00597246	Memorial Sloan Kettering Cancer Center	N/A
Completed	Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma NCT00588523	Memorial Sloan Kettering Cancer Center	Phase 2
Terminated	Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9 NCT00582608	Memorial Sloan Kettering Cancer Center	N/A
Completed	Spectroscopy With Surface Coils and Decoupling NCT00581815	Memorial Sloan Kettering Cancer Center	Phase 1